Esperion Lipid Research Headed By Former Parke-Davis Scientists
Executive Summary
Start-up Esperion Therapeutics' efforts to develop pharmacological approaches to lipid removal will be led by four high-level basic research scientists from Warner-Lambert's Parke-Davis division.